Opportunity overview
The Fleming Fund supports Lower Middle Income Countries (LMICs) to tackle the deadly global impact of antimicrobial resistance (AMR) by improving laboratory capacity, diagnosis and building sustainable surveillance systems, taking a One Health approach. DHSC anticipates needing a Management Agent to deliver the aims of phase III of the Fleming Fund.<br/><br/>This is the first in a series of market engagement events to engage with the market on the anticipated Phase III procurement.
Classification
- CPV75211200 — Foreign economic-aid-related services
- CPV85100000 — Health services
Lots
- The Fleming Fund supports Lower Middle Income Countries (LMICs) to tackle the deadly global impact of antimicrobial resistance (AMR) by improving laboratory capacity, diagnosis and building sustainable surveillance systems, taking a One Health approach. DHSC anticipates needing a Management Agent to deliver the aims of phase III of the Fleming Fund.<br/><br/>This is the first in a series of market engagement events to engage with the market on the anticipated Phase III procurement. <br/><br/>There Authority will host a will be a market engagement day on 20 March 2025 from 10:00 - 12:00. <br/>Interested attendees are required to RSVP by 17:00 on 18th March 2025. Additional information: This will be a virtual event. <br/><br/>Clarification questions are permitted until 14th March 2025.<br/><br/>The budget for Phase III of the Fleming Fund is yet to be finalised, it is anticipated that the budget will be similar to Phase I and Phase II, however the Authority will confirm at later market engagement events.Value not stated